Mutations causing MYH9-related disease therefore cause thrombocytopenia through the most proximal part of platelet formation, where a disruption in the Rho-Rho kinase-myosin IIA pathway leads to a lack of reactivation of NMMHC-IIA. The gene discussed is MYH9; the disease is Thrombocytopenia.